Skip to main content

Myeloproliferative Neoplasms and Mastocytosis

  • Chapter
  • First Online:
Atlas of Bone Marrow Pathology

Part of the book series: Atlas of Anatomic Pathology ((AAP))

  • 2424 Accesses

Abstract

This chapter covers the myeloproliferative neoplasms (MPNs) and mastocytosis. The MPNs are clonal neoplasms characterized by increased bone marrow cellularity, organomegaly, and increased effective cellular maturation resulting in elevated blood levels of one or more cell lines (erythrocytosis, leukocytosis, thrombocytosis). Though dysplasia is typically absent, the MPNs can evolve into acute leukemia or an end-stage myelofibrosis. The disease course is typically long, developing over many years. A common theme of tyrosine kinase activation unites the MPNs, including mastocytosis. There is considerable overlap of clinical, laboratory, and pathologic features for many of these neoplasms; over time, one type of MPN may develop features of another. Figures and tables willillustrate the bone marrow pathology of the MPNsĀ and mast cell disease, including relevant clinical, laboratory, cytogenetic, and molecular genetic findings

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391ā€“405.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  2. Horny H-P, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L, Valent P. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 54ā€“63.

    Google ScholarĀ 

  3. Guglielmelli P, Pacilli A, Rotunno G, Rumi E, Rosti V, Delaini F, et al. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood. 2017. [Epub ahead of print]. https://doi.org/10.1182/blood-2017-01-761999.

  4. Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128ā€“32.

    PubMedĀ  Google ScholarĀ 

  5. Kvasnicka HM, Beham-Schmid C, Bob R, Dirnhofer S, Hussein K, Kreipe H, et al. Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosisĀ ā€“ a consensus-based study. Histopathology. 2016;68:905ā€“15.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  6. Arredondo AR, Gotlib J, Shier L, Medeiros B, Wong K, Cherry A, et al. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol. 2010;85:600ā€“6.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

Suggested Reading

  • Chabot-Richards D, Shier LR, George TI. Pathology of the myeloproliferative neoplasms. In: Greer JP, Appelbaum F, Arber DA, Dispenzieri A, Fehniger T, Glader B, et al., editors. Wintrobeā€™s clinical hematology. 14th ed. (in press) ed. Philadelphia: Lippincott Williams and Wilkins; 2017.

    Google ScholarĀ 

  • George TI, Sotlar K, Valent P, Horny H-P. Mastocytosis. In: Jaffe ES, Arber DA, Harris NL, Quintanilla-Martinez L, editors. Hematopathology. 2nd ed. Philadelphia: Elsevier; 2017. p. 911ā€“30.

    Google ScholarĀ 

  • Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013;122:1707ā€“11.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  • Reiter A, Gotlib J. Myeloid neoplasms with eosinophilia. Blood. 2017;129:704ā€“14.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Wang SA, Tam W, Tsai A, Arber DA, Hasserjian RP, Geyer JT, et al. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol. 2016;29:854ā€“64.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  • Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, et al. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified from reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017. [Epub ahead of print]. https://doi.org/10.3324/haematol.2017.165340.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tracy I. George .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2018 Springer Science+Business Media, LLC

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shier, L.R., George, T.I. (2018). Myeloproliferative Neoplasms and Mastocytosis. In: George, T., Arber, D. (eds) Atlas of Bone Marrow Pathology. Atlas of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7469-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7469-6_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7467-2

  • Online ISBN: 978-1-4939-7469-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics